- Home
- CVV vs ESLA Comparison
CVV vs ESLA Comparison
Compare CVV & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVV | ESLA |
|---|---|---|
| Founded | 1982 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.3M | 33.6M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVV | ESLA |
|---|---|---|
| Price | $7.33 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 72.7K | 43.7K |
| Earning Date | 05-12-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,128,639.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 96.27 | N/A |
| 52 Week Low | $2.76 | $0.73 |
| 52 Week High | $8.76 | $3.15 |
Technical Indicators
Market Signals| Indicator | CVV | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 49.28 | 36.89 |
| Support Level | $6.46 | $0.73 |
| Resistance Level | $8.47 | $1.28 |
| Average True Range (ATR) | 0.58 | 0.09 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 21.16 | 16.76 |
Price Performance
Historical ComparisonAbout CVV CVD Equipment Corporation
CVD Equipment Corp designs, develops, and manufactures a broad range of equipment used to develop and produce materials and coatings for the aerospace, compound semiconductor, semiconductor, aerospace, battery energy storage markets as well as industrial applications, and research. It currently conducts its business through two reportable segments: CVD Equipment, which designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; and SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems. Its target markets are aerospace & defense and industrial, microelectronics / high power electronics, and EV battery materials / energy storage.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.